EE03879B1 - LH-RH peptiidi analoogid, nende kasutamine ja neid sisaldavad farmatseutilised kompositsioonid - Google Patents

LH-RH peptiidi analoogid, nende kasutamine ja neid sisaldavad farmatseutilised kompositsioonid

Info

Publication number
EE03879B1
EE03879B1 EEP199900546A EEP9900546A EE03879B1 EE 03879 B1 EE03879 B1 EE 03879B1 EE P199900546 A EEP199900546 A EE P199900546A EE P9900546 A EEP9900546 A EE P9900546A EE 03879 B1 EE03879 B1 EE 03879B1
Authority
EE
Estonia
Prior art keywords
pharmaceutical compositions
compositions containing
peptide analogs
analogs
peptide
Prior art date
Application number
EEP199900546A
Other languages
English (en)
Inventor
Delansorne R�mi
Paris Jacques
Original Assignee
Laboratoire Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex filed Critical Laboratoire Theramex
Publication of EE9900546A publication Critical patent/EE9900546A/et
Publication of EE03879B1 publication Critical patent/EE03879B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EEP199900546A 1997-06-02 1998-05-06 LH-RH peptiidi analoogid, nende kasutamine ja neid sisaldavad farmatseutilised kompositsioonid EE03879B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97401212A EP0882736A1 (en) 1997-06-02 1997-06-02 LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
PCT/EP1998/002802 WO1998055505A1 (en) 1997-06-02 1998-05-06 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
EE9900546A EE9900546A (et) 2000-06-15
EE03879B1 true EE03879B1 (et) 2002-10-15

Family

ID=8229769

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900546A EE03879B1 (et) 1997-06-02 1998-05-06 LH-RH peptiidi analoogid, nende kasutamine ja neid sisaldavad farmatseutilised kompositsioonid

Country Status (38)

Country Link
US (1) US6586402B1 (et)
EP (2) EP0882736A1 (et)
JP (1) JP4346115B2 (et)
KR (1) KR100582510B1 (et)
CN (1) CN1134450C (et)
AP (1) AP1195A (et)
AR (1) AR011734A1 (et)
AT (1) ATE204297T1 (et)
AU (1) AU746132B2 (et)
BR (1) BR9809910A (et)
CA (1) CA2292846C (et)
CO (1) CO4790174A1 (et)
CZ (1) CZ299308B6 (et)
DE (1) DE69801369T2 (et)
DK (1) DK0984982T3 (et)
DZ (1) DZ2509A1 (et)
EE (1) EE03879B1 (et)
ES (1) ES2166166T3 (et)
HK (1) HK1029124A1 (et)
HU (1) HUP0003592A3 (et)
ID (1) ID24520A (et)
IL (1) IL133210A0 (et)
JO (1) JO2034B1 (et)
MA (1) MA26502A1 (et)
MY (1) MY122262A (et)
NO (1) NO321786B1 (et)
NZ (1) NZ501463A (et)
OA (1) OA11305A (et)
PE (1) PE84999A1 (et)
PL (1) PL195474B1 (et)
PT (1) PT984982E (et)
RU (1) RU2212247C2 (et)
SI (1) SI0984982T1 (et)
TN (1) TNSN98075A1 (et)
TR (1) TR199902997T2 (et)
TW (1) TW479062B (et)
WO (1) WO1998055505A1 (et)
ZA (1) ZA983992B (et)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
US20020071829A1 (en) * 1999-04-15 2002-06-13 Richard Boyd Normalization of defective T cell responsiveness through manipulation of thymic regeneration
CA2462046A1 (en) * 2000-10-13 2002-04-18 Monash University Improvement of graft acceptance through manipulation of thymic regeneration
GB0307777D0 (en) 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
DE102004033902A1 (de) * 2004-07-14 2006-02-16 Zentaris Gmbh Neue Tetrahydrocarbazolderivate mit verbesserter biologischer Wirkung und verbesserter Löslichkeit als Liganden für G-Protein gekoppelte Rezeptoren (GPCR's)
CN105384807A (zh) * 2005-12-14 2016-03-09 Ambrx公司 含有非天然氨基酸和多肽的组合物、涉及非天然氨基酸和多肽的方法以及非天然氨基酸和多肽的用途
CN102675418B (zh) * 2011-03-15 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物、其制备方法及用途
CN110133299A (zh) * 2012-03-18 2019-08-16 株式会社资生堂 疾病样品分析装置、分析系统及分析方法
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9393264B2 (en) * 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
CN104418936B (zh) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物及其药物用途
CN114014913B (zh) * 2022-01-10 2022-03-29 浙江湃肽生物有限公司南京分公司 醋酸曲普瑞林的纯化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO139560C (no) * 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NL7505590A (nl) * 1974-05-18 1975-11-20 Hoechst Ag Werkwijze voor het bereiden van peptiden met lh-rh/fsh-rh-werking.
DE2424287A1 (de) * 1974-05-18 1975-12-04 Hoechst Ag Peptide mit lh-rh/fsh-rh-wirkung und verfahren zu ihrer herstellung
US4565804A (en) * 1984-09-07 1986-01-21 The Salk Institute For Biological Studies GnRH Antagonists VI
US5003011A (en) * 1985-04-09 1991-03-26 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
WO1989007450A1 (en) * 1988-02-10 1989-08-24 Abbott Laboratories Lhrh analogs
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EE9900546A (et) 2000-06-15
MY122262A (en) 2006-04-29
MA26502A1 (fr) 2004-12-20
JP4346115B2 (ja) 2009-10-21
PL337235A1 (en) 2000-08-14
DZ2509A1 (fr) 2003-01-25
JO2034B1 (en) 1999-05-15
HUP0003592A3 (en) 2001-05-28
CN1134450C (zh) 2004-01-14
DK0984982T3 (da) 2001-11-12
US6586402B1 (en) 2003-07-01
TW479062B (en) 2002-03-11
ATE204297T1 (de) 2001-09-15
ZA983992B (en) 1998-11-20
CZ299308B6 (cs) 2008-06-11
ES2166166T3 (es) 2002-04-01
CA2292846A1 (en) 1998-12-10
AP9901702A0 (en) 1999-12-31
NO995891L (no) 2000-02-01
BR9809910A (pt) 2000-08-01
DE69801369D1 (de) 2001-09-20
ID24520A (id) 2000-07-20
CO4790174A1 (es) 1999-05-31
AP1195A (en) 2003-08-18
NO995891D0 (no) 1999-12-01
EP0882736A1 (en) 1998-12-09
TNSN98075A1 (fr) 2005-03-15
NO321786B1 (no) 2006-07-03
AU7654198A (en) 1998-12-21
CN1263535A (zh) 2000-08-16
CZ432999A3 (cs) 2000-06-14
OA11305A (en) 2003-08-25
TR199902997T2 (xx) 2000-03-21
NZ501463A (en) 2001-07-27
AU746132B2 (en) 2002-04-18
AR011734A1 (es) 2000-08-30
RU2212247C2 (ru) 2003-09-20
CA2292846C (en) 2009-12-08
EP0984982A1 (en) 2000-03-15
HK1029124A1 (en) 2001-03-23
PE84999A1 (es) 1999-09-15
HUP0003592A2 (hu) 2001-02-28
SI0984982T1 (en) 2002-02-28
PT984982E (pt) 2002-02-28
EP0984982B1 (en) 2001-08-16
DE69801369T2 (de) 2002-05-16
WO1998055505A1 (en) 1998-12-10
KR100582510B1 (ko) 2006-05-23
JP2002502396A (ja) 2002-01-22
KR20010013286A (ko) 2001-02-26
PL195474B1 (pl) 2007-09-28
IL133210A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
EE03879B1 (et) LH-RH peptiidi analoogid, nende kasutamine ja neid sisaldavad farmatseutilised kompositsioonid
EE200000168A (et) Karboksamidotiasoolderivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid
EE9800028A (et) Iprotroopiumsoolad, neid sisaldavad ravimkompositsioonid ja nende kasutamine
EE04815B1 (et) 6,9-diasendatud-2-[trans-(4-aminotsükloheksüül)amino]puriinid, neid sisaldavad farmatseutilised kompositsioonid ja nende kasutamine
ATE230611T1 (de) Pharmazeutische zusammensetzungen mit plasmaproteinen
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
ATE246490T1 (de) Pharmazeutische zusammensetzung von topiramate
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
FI973279A0 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
DE69822209D1 (de) ESTRON-SULFatase HEMMENDE ESTRON-SULFAMATVERBINDUNGEN, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON
EE03692B1 (et) 19-nor-pregneeni derivaadid, mis omavad progestaatilist toimet ja neid sisaldavad farmatseutilised kompositsioonid
ATE222751T1 (de) Pharmazeutische aerosolzusammensetzung
NO20001914D0 (no) <alfa>-Aryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike
DK1112266T3 (da) Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
HUP0002272A3 (en) Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use
IL122740A0 (en) 16-hydroxy-11-(substituted phenyl)-estra-9, 4-diene derivatives their preparation and pharmaceutical compositions containing them
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
DE69830154D1 (de) Pharmazeutische zusammensetzungen
DE69816124D1 (de) Pharmazeutische zusammensetzungen enthaltend zafirlukast
EE9900174A (et) Konformatsiooniliselt fikseeritud LH-RH analoogid, nende kasutamine ja neid sisaldavad farmatseutilised kompositsioonid
HUP9802590A3 (en) Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them
EE04347B1 (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, neid sisaldav ravim ja farmatseutiline kompositsioon
DE69812962T2 (de) Oral anzuwendende Arzneizubereitung enthaltend S-(3-Hydroxypropyl)-L-Cystein
EE03179B1 (et) Asendatud 2-propanooli derivaadid, neid sisaldavad farmatseutilised segud ja nende valmistamise protsessid

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20120506